Mergers & Antitrust Law News

Vertical Mergers Like CVS-Aetna Need New Guidelines, Senator Says

Aug. 21, 2018, 6:07 PM

U.S. antitrust regulators should adopt tougher guidelines on vertical mergers such as CVS Health Corp.’s $68 billion bid to acquire insurer Aetna Inc., Sen. Richard Blumenthal (D-Conn.) said in comments filed with the Federal Trade Commission.

The government’s current guidelines on mergers between companies that compete in different markets have kept enforcement “stubbornly stuck in the past,” according to Blumenthal’s filing, announced Aug. 21. The guidelines haven’t been revised since 1984.

The filing is part of the FTC solicitation for public comments in preparation for a series of hearings on competition and consumer protection policy. The deadline for submission...

To read the full article log in. To learn more about a subscription click here.